A carregar...
Updates on managing advanced breast cancer with palbociclib combination therapy
BACKGROUND: The objective of this study was to review the pharmacology, efficacy, and safety of palbociclib, a first-in-class cyclin-dependent kinase 4/6 inhibitor, for the management of advanced breast cancer (ABC). METHODS: Pharmacokinetics and drug interactions associated with palbociclib are des...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6122240/ https://ncbi.nlm.nih.gov/pubmed/30202448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918793849 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|